HIGHLIGHTS
- who: Shi Yan from the Indian Institute of Technology Indore, Anhui Medical University, China have published the article: Dupilumab improves clinical symptoms in children with Netherton syndrome by suppressing Th2-mediated inflammation, in the Journal: (JOURNAL)
- what: In regarding to the drug safety, only two patients in this study have reported mild ocular symptoms, which similar to that in treatment of atopic dermatitis, in the entire 20-week treatment period.
- how: Cells were examined immediately using a BD FACS-CantoII and data were analyzed using FlowJo software (TreeStar USA).
- future: The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.